PRVAPrivia Health Group, Inc.

$20.78

$20.0252 weeks$28.10

Price

$20.78-2.8%1Y

1M-5.6%1Y-2.8%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Lagging

2/10

Value16

Quality58

Momentum24

Growth69

Strongest Growth, weakest Value · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

What they do

Under our Privia Medical Group model, Privia Physicians join the Medical Group in their geographic market as an owner of the Medical Group. We own a majority interest in certain of our Medical Groups (each, an “Owned Medical Group”), with Privia Physicians collectively owning a minority interest, and we own no interest in certain other Medical Groups for which we provide services through a services agreement (each, a “Non-Owned Medical Group”).

In the company’s own words · 10-K filed Feb 27, 2026 · SEC EDGAR

P/E (TTM)99.0

Market Cap$3.09B

1Y Return-2.8%

5Y Return-38%

Business segments

Q2 2026 · $632.6M

The company’s own SEC segment disclosure.

FFS Patient Care$412.6M65%
Capitated$95.2M15%
Shared Savings$68.9M11%
FFS Administrative Services$33.2M5%
Care Management Fee PMPM$20.7M3%
Other$2.0M0%

Privia Health Group, Inc. (PRVA) reported revenue of $633M in Q2 2026 (quarter ended Jun 30, 2026), up 21% from the same quarter a year earlier. That came with net income of $9.0M (1.4% of revenue). For the full year FY2025, revenue was $2.12B (+22% year on year) and net income $23M. Its largest product in Q2 2026 was FFS Patient Care at $413M, 65% of the disclosed total, well ahead of Capitated at 15%.

Raw charts

10 series · TTM

As reported to the SEC, without any scoring.

Health Information Services

Ranks #12 of 13 by Smart Score

Waystar Holding Corp.